{"id":60,"date":"2019-01-31T17:17:45","date_gmt":"2019-01-31T08:17:45","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/en\/?page_id=60"},"modified":"2019-02-01T13:22:57","modified_gmt":"2019-02-01T04:22:57","slug":"achievements2014","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/achievements\/achievements2014\/","title":{"rendered":"2014"},"content":{"rendered":"<h4><strong>English-language papers(\u203bcorresponding author)<\/strong><\/h4>\n<ol>\n<li>Kibria G., Hatakeyama H.,Akiyama K.,<em><u>\u00a0<\/u><\/em><u>Hida K<\/u>. and *Harashima H.: Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships between the Effect of the Drug-Efflux Pump P-gp,\u00a0<strong><em>Biol. Pharm. Bull,\u00a0<\/em><\/strong>37(12), 1926\u20131935, 2014<\/li>\n<li>Akhter A., Hayashi Y., Sakurai Y., Ohga N.,\u00a0<u>Hida K.<\/u>, *Harashima H.: Ligand density at the surface of a nanoparticle and different uptake mechanism: Two important factors for successful siRNA delivery to liver endothelial cells,\u00a0<strong><em>Int J Pharm<\/em><\/strong>, 475 (1-2):227-237, 2014<\/li>\n<li>Ohmura-Kakutani H., Akiyama K., Maishi N., Ohga N., Hida Y., Kawamoto T., Iida J., Shindoh M., Tsuchiya K., Shinohara N.,\u00a0<u>*Hida K.<\/u>\uff1aIdentification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype,<strong><em>PLoS ONE<\/em><\/strong>, \u00a09(12):e113910, 2014<\/li>\n<li>Ara MN., Matsuda T., Hyodo M, Sakurai Y, Ohga N.,\u00a0<u>Hida K.<\/u>\uff1aConstruction of an aptamer modified liposomal system targeted to tumor endothelial cells,\u00a0<strong><em>Bio Pharm Bull,\u00a0<\/em><\/strong>37(11):1742-9, 2014<\/li>\n<li>Alam MT\uff0c Nagao-Kitamoto H., Ohga N., Akiyama K., Maishi N., \u00a0Kawamoto T., Shinohara N., Taketomi A., Shindoh M., Hida Y. and *<u>Hida K<\/u>.\uff1aSuprabasin as a novel tumor endothelial cell marker,\u00a0<strong><em>Cancer Sci<\/em><\/strong>, 105(12), 1533\u20131540, 2014<\/li>\n<li>Ara MN., Matsuda T., Hyodo M, Sakurai .Y, Hatakeyama H., Ohga N.,\u00a0<u>Hida K.<\/u>, Harashima H. \uff1aAn aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells\uff0c<strong><em>Biomaterials<\/em><\/strong>, 35(25), 7110-7120, 2014<\/li>\n<li>Ara MN., Hyodo M., Ohga N., Akiyama K.,\u00a0<u>Hida K<\/u>., Hida Y., Shinohara N., Harashima H.\uff1aIdentification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand,\u00a0<strong><em>Cancer Med<\/em><\/strong>, 3(4), 825-834, 2014<\/li>\n<li>Otsubo T., Hida Y., Ohga N., Sato H., Kai T., Matsuki Y., Takasu H., Akiyama K., Maishi N., Kawamoto T., Shinohara N., Nonomura K., *Hida K.\uff1aIdentification of Novel Targets for Antiangiogenic Therapy by Comparing the Gene Expressions of Tumor and Normal Endothelial Cells,\u00a0<b><i>Cancer Sci<\/i><\/b>, 105(5), 560-567, 2014<\/li>\n<li>Habiba U., Kitamura T. Yanagawa-Matsuda A., Hida K., Higashino F., Ohiro Y., Totsuka Y. and Shindoh M.\uff1aCytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions,<b><i>\u00a0Oncol Rep<\/i><\/b>, 31(4), 1547-1554, 2014<\/li>\n<li>Sakurai Y., Hatakeyama H., Sato Y., Hyodo M., Akita H.,Ohga N.,\u00a0<u>Hida K.<\/u>, Harashima H.\uff1aRNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system,\u00a0<strong><em>J Control Release<\/em><\/strong>, 173(10), 110-118, 2014<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>English-language papers(\u203bcorresponding author) Kibria G., Hatakeyama H.,Akiyama K.,\u00a0Hida K. and *Harashima H.: Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships &#8230;<a class=\"moretag\" href=\"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/achievements\/achievements2014\/\">\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":19,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-60","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/60","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/comments?post=60"}],"version-history":[{"count":2,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/60\/revisions"}],"predecessor-version":[{"id":78,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/60\/revisions\/78"}],"up":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/19"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/media?parent=60"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}